Immunomodulatory IL-2 agents in combination with immune checkpoint inhibitors Grant US-11945870-B2 United States of America 02 Apr 2024
CELL-MEDIATED TRANSIENT DELIVERY OF IMMUNE-ENHANCING MOLECULES INTO THE TUMOR… Application EP-4061928-A4 European Patent Office 20 Dec 2023
T CELL RECEPTORS TARGETING DEFECTIVE DNA REPAIR PROTEINS Application EP-4099989-A4 European Patent Office 13 Dec 2023
COMPOSITIONS TARGETING GPC2 AND GPC3 AND THEIR USE FOR TREATING SOLID TUMORS Application WO-2023215738-A1 World Intellectual Property Organisation (WIPO) 09 Nov 2023